Find out how the company's da Vinci surgical robots could remain the preferred option for decades.Shares of Intuitive Surgical (ISRG -3.56%) are down about 26% from a high-water mark they set earlier this year, but the healthcare stock's long-term shareholders aren't too upset. Despite the recent decline, shares of the robot-assisted surgical system provider are up by a whopping 5,490% over the past 20 years.Shares of Intuitive Surgical have been beaten down this year in response to a competitive threat fro ...

Key Takeaways ISRG's Ion procedures rose 52% in Q2 2025, with global installs reaching 905 systems.ISRG's gross margin slipped to 67.9% on Ion mix, da Vinci 5 sales, and tariff headwinds.ISRG is prioritizing Ion cost efficiency to offset tariffs and protect profitability.Intuitive Surgical’s (ISRG) Ion platform is rapidly scaling, with procedures surging 52% year over year to 35,000 in second-quarter 2025. Yet management’s commentary made clear that Ion’s next growth phase hinges not only on utilization gai ...